D2 Solutions, a Chesterfield-based provider of software and consulting for the health care industry, has landed a revenue-based financing deal.
The company said the seven-figure funding package is from Decathlon Capital Partners, a Park City, Utah-based investor, according to a recent press release. The exact amount and other details of the financing weren't disclosed.
D2 Solutions said it will use the new capital to expand its platform development, strengthen its customer service operations, and add new software-as-a-service (SaaS) offerings.
The company says that, through its consulting services and technology, it works with manufacturers, pharmacies, payers, pharmacy benefit managers and hospital systems to increase efficiency, minimize risk and expand access in the prescription drug sector.
Decathlon Capital Partners, which also has offices in Palo Alto, California, says it is the nation's largest revenue-based funding investor. Its revenue-based financing allows a business to repay a capital infusion through monthly payments based on a percentage of future revenue.
Dean Erhardt, Chief Executive Officer of D2 Solutions, said D2 Solutions has helped more than 500 healthcare industry partners work toward increased efficiency, decreased risks, and expanded access in the prescription realm.
"By combining consulting with technology, we are able to develop real-world solutions for our partners," Dean Erhardt, CEO of D2 Solutions, said in the release. "This is a market that's constantly changing, and we're here to help manufacturers, pharmacies, and hospitals bridge the gap with our team of industry experts."
